1.
Clin J Oncol Nurs
; 18(5): 497-500, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25253103
RESUMO
Although the known risks of exposure to hazardous drugs have been well documented and disseminated, certain barriers remain in the use of personal protective equipment (PPE) by nurses administering chemotherapy. At Dana-Farber Cancer Institute, a program was developed that incorporated not only monitoring and reporting compliance of the use of PPE, but also engaged the staff in audit and reporting activities. Compliance rates improved dramatically over time and have remained at high levels.